等待開盤 09-10 09:30:00 美东时间
0.000
0.00%
NANO Nuclear Energy Inc. (NASDAQ:NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, is proud to announce its execution of a
09-04 19:31
Kronos Worldwide, Inc. announced plans to raise €75 million through a private offering of 9.50% Senior Secured Notes due 2029 by its subsidiary Kronos International, Inc. These notes have the same terms as the existing €351.174 million notes issued in 2024, except for issuance date and price. They will trade separately for 40 days before consolidating with existing notes. The offering is secured by the company and its subsidiaries and is intended...
09-03 06:30
NANO Nuclear Energy Inc. (NASDAQ:NNE) ("NANO Nuclear" or the "Company"), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced it has been awarded a Direct
09-02 18:10
KRONOS Worldwide (NYSE:KRO) declares $0.05/share quarterly dividend, in line with previous. Payable Sept. 18; for shareholders of record Sept. 5; ex-div Sept. 5. See KRO Dividend Scorecard, Yield Char...
08-07 10:07
Kronos Worldwide, Inc. announced a regular quarterly dividend of $0.05 per share, payable on September 18, 2025, to stockholders of record at the close of business on September 5, 2025. The company is a major international producer of titanium dioxide products.
08-06 20:15
NANO Nuclear Energy Inc. (NASDAQ:NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that it will provide
07-14 18:06
Kronos Bio ( ($KRON) ) has provided an update. On June 20, 2025, Kronos Bio, In...
06-20 23:14
Kronos Bio shares are trading higher after the company announced the terminatio...
06-05 20:42
KRONOS Worldwide (NYSE:KRO) declared $0.05/share quarterly dividend, in line with previous. Payable June 18; for shareholders of record June 9; ex-div June 9. See KRO Dividend Scorecard, Yield Chart, ...
05-15 05:41
Kronos Bio (NASDAQ:KRON), an oral drug developer targeting cancer and other diseases, announced Thursday a merger agreement to be acquired by San Diego, California-based biotech Concentra Biosciences,...
05-01 20:49